πŸ‡ΊπŸ‡Έ FDA
Patent

US 7960398

Regulation of TNF-alpha

granted A61KA61K38/00

Quick answer

US patent 7960398 (Regulation of TNF-alpha) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jun 14 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K38/00